These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19409761)

  • 1. Artesunate plus sulfamethoxypyrazine/pyrimethamine for the treatment of cutaneous leishmaniasis: a double-blind, placebo-controlled clinical trial.
    Adam I; Hagelnur AA
    Int J Antimicrob Agents; 2009 Oct; 34(4):380-1. PubMed ID: 19409761
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-label randomised controlled trial.
    Obonyo CO; Muok EM; Mwinzi PN
    Lancet Infect Dis; 2010 Sep; 10(9):603-11. PubMed ID: 20705516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
    J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis.
    Sadeghian G; Nilforoushzadeh MA
    Int J Dermatol; 2006 Jul; 45(7):819-21. PubMed ID: 16863518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind, comparative clinical trial on the efficacy and safety of intralesional sodium stibogluconate and intralesional 7% hypertonic sodium chloride against cutaneous leishmaniasis caused by L. donovani.
    Ranawaka RR; Weerakoon HS
    J Dermatolog Treat; 2010 Sep; 21(5):286-93. PubMed ID: 20438389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis.
    Nassiri-Kashani M; Firooz A; Khamesipour A; Mojtahed F; Nilforoushzadeh M; Hejazi H; Bouzari N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):80-3. PubMed ID: 15649196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double blind, randomised placebo controlled trial of rifampicin with omeprazole in the treatment of human cutaneous leishmaniasis.
    Kochar DK; Saini G; Kochar SK; Sirohi P; Bumb RA; Mehta RD; Purohit SK
    J Vector Borne Dis; 2006 Dec; 43(4):161-7. PubMed ID: 17175700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimony plus recombinant human granulocyte-macrophage colony-stimulating factor applied topically in low doses enhances healing of cutaneous Leishmaniasis ulcers: a randomized, double-blind, placebo-controlled study.
    Santos JB; de Jesus AR; Machado PR; Magalhães A; Salgado K; Carvalho EM; Almeida RP
    J Infect Dis; 2004 Nov; 190(10):1793-6. PubMed ID: 15499535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent preventive therapy for malaria: arguments in favour of artesunate and sulphamethoxypyrazine - pyrimethamine combination.
    Jansen FH
    Malar J; 2011 Mar; 10():70. PubMed ID: 21443809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel.
    Wortmann G; Miller RS; Oster C; Jackson J; Aronson N
    Clin Infect Dis; 2002 Aug; 35(3):261-7. PubMed ID: 12115091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hexadecyl-phosphorylcholine ointment for treatment of cutaneous leishmaniasis: an animal trial.
    Iqbal J; Bukhari I; Jamshid M; Bashir S; Masoom Yasinzai M; Anwar M
    East Mediterr Health J; 2006 Sep; 12(5):685-9. PubMed ID: 17333810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of New World cutaneous leishmaniasis with miltefosine.
    Soto J; Berman J
    Trans R Soc Trop Med Hyg; 2006 Dec; 100 Suppl 1():S34-40. PubMed ID: 16930649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of artesunate + sulfamethoxypyrazine/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children.
    Sissoko MS; Dabo A; Traoré H; Diallo M; Traoré B; Konaté D; Niaré B; Diakité M; Kamaté B; Traoré A; Bathily A; Tapily A; Touré OB; Cauwenbergh S; Jansen HF; Doumbo OK
    PLoS One; 2009 Oct; 4(10):e6732. PubMed ID: 19802383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, randomized, clinical trial on the antileishmanial activity of a Morinda citrifolia (Noni) stem extract and its major constituents.
    Sattar FA; Ahmed F; Ahmed N; Sattar SA; Malghani MA; Choudhary MI
    Nat Prod Commun; 2012 Feb; 7(2):195-6. PubMed ID: 22474954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete cure of a large complex cutaneous leishmaniasis with a nonethanolic lipid based-amphotericin B gel.
    Gupta A; Sardana K; Ahuja A; Kishan Gautam R
    Clin Exp Dermatol; 2019 Oct; 44(7):807-810. PubMed ID: 30592076
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis.
    Soto J; Valda-Rodriquez L; Toledo J; Vera-Navarro L; Luz M; Monasterios-Torrico H; Vega J; Berman J
    Am J Trop Med Hyg; 2004 Nov; 71(5):577-81. PubMed ID: 15569787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Itraconazole in the treatment of cutaneous leishmaniasis.
    Firooz A; Khatami A; Dowlati Y
    Int J Dermatol; 2006 Dec; 45(12):1446-7. PubMed ID: 17184256
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acute ocular toxoplasmosis--case report].
    Mihu IV; Tudor CM
    Oftalmologia; 2002; 52(1):38-40. PubMed ID: 12677798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a Single Oral Dose of Artesunate plus Sulfalene-Pyrimethamineversus Praziquantel in the Treatment of Schistosoma mansoni in Kenyan Children: An Open-Label, Randomized, Exploratory Trial.
    Muok EMO; Were VO; Obonyo CO
    Am J Trop Med Hyg; 2024 Apr; 110(4):677-680. PubMed ID: 38460198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study.
    Esfandiarpour I; Dabiri SH
    Int J Dermatol; 2007 Aug; 46(8):848-52. PubMed ID: 17651170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.